RETA Reata Pharmaceuticals Inc

🔔Trading Update🔔 📅Tuesday 24/01/2023📅 🟢Bullish Activity🟢 $DHI Reaching 52-week high this morning after the home builder reported fiscal Q1 earnings of $2.76 per share$0.52 beat on revenue that rose 2.9% YOY to $7.26B above the $6.43B consensus. Q1 net sales orders decreased 38% YOY to 13382 homes and Q1 sales order backlog of homes under contract decreased 46% to 15759 homes both YOY. The February 17th 100.00 call being the highest volume contract. $BX Also to the upside after J.P. Morgan upgraded the investment banking company to Overweight from Neutral and bumped their price target on the stock to $105.00 from $104.00. Analysts said that Blackstone’s retail franchise business is still intact and sees stronger growth over the intermediate term. The June 16th 87.50 put being the highest volume contract. New 52-week highs: ( $RETA + $3.79 to $45.71) 🟢Notable Calls🟢 $MARA Some unusual activity seen which primarily target the March 17th 15.00 call. Volume on this contract